Monthly Archives: January 2018

Gastric band Surgery In France Do liver cleanses work? Evidence and risks Liver cleanses promise to rid the body of toxins and impurities, but they are controversial because there is little science to support their use.Products that claim to detox the liver might even be dangerous, and the United States Food and Drug Administration (FDA) do not regulate them. In this article, we look at how liver cleanses claim to work and what evidence exists to support them. What is a liver cleanse? A liver cleanse may involve may involve choosing or avoiding specific foods, or going on a juice fast. The liver is the body’s natural detoxifier, as it cleanses the body of toxins and produces bile to support healthy digestion. A healthy liver can detoxify almost everything that a person encounters. The liver is on the right side of the body, just under the rib cage, When the liver is diseased, the body cannot filter out toxic substances as efficiently. This can cause a wide range of symptoms, including: A variety of natural health practitioners, supplement companies, and medical websites argue that the liver accumulates toxins during the filtering process. They insist that over time, these toxins can cause a range of nonspecific symptoms and may even cause serious diseases or increase the risk of cancer. There is little evidence to support this. Over time, however, exposure to chemicals can damage the liver. For example, drinking alcohol is a well-known way to ruin liver function over time. In most cases, a liver detox involves one or more of the following: taking supplements designed to flush toxins out of the liver eating a liver-friendly diet avoiding certain foods going on a juice fast cleansing the colon and gut through the use of enemas While liver failure is a serious health problem, there is no evidence that dangerous toxins accumulate in otherwise healthy livers without specific exposure to large amounts of these chemicals. Mainstream medical practitioners argue that the liver does not need detoxing and that doing so might even be dangerous. < !13902-20180111154925!> < !13902-20180111155034!> < !13902-20180111155119!> < !13902-20180111155208!> Should you try a liver cleanse? A healthy liver is crucial for maintaining a person’s overall health, but expensive cleanses or diets are just not necessary. In some cases, they may even be dangerous. A healthy lifestyle, balanced diet, and regular consultations with a doctor are far more valuable to the health of the liver than any fad diet or cleanse. For FREE No Obligation Information about the cost of Gastric Band Surgery in France Click here Or Click the Image Below to visit our Special offer Page to see if you Qualify for any Discounts Read more……>click Here< Read more…

Gastric band Surgery In France Diabetes: New pathway to treatment suggested by protein culprit What is the link between anxiety and diabetes? New research shows that a protein related to the development of anxiety and depression may also play a role in triggering diabetes. Scientists from the Max Planck Institutes hypothesize that an antagonist compound could be used to block its effect. Scientists investigate a new lead in the search for better diabetes treatments. The main known causes for type 2 diabetes so far include obesity and lack of physical exercise – both of which can lead to insulin resistance – as well as a family history of the condition. Insulin resistance occurs when muscles, liver, and fat cells become unable to use insulin appropriately, which ultimately leads to a dangerous rise in blood glucose levels. Now, researchers from the Max Planck Institute of Psychiatry in Munich, Germany, have found that a protein called FKBP51 may also play a role in triggering type 2 diabetes. The protein has so far been associated with anxiety and depression; it contributes to the regulation of the stress system. When the gene that controls the production of FKBP51 suffers a mutation, this can lead to dysregulation of the stress system, which, in turn, can cause mental health disorders. Mathias Schmidt – lead researcher of the current study – and colleagues have recently noted that the FKBP51 protein also contributes to forming a molecular link between the stress system and the regulation of various metabolic functions. This may make FKBP51 responsible for the onset of metabolic diseases such as obesity and diabetes. The team’s findings have now been published in the journal Nature Communications. Protein reacts to metabolic stress Schmidt and team looked at a mouse model to understand the potential role played by FKBP51 in metabolic processes. They studied the effect of a high-fat diet on mice in which the FKBP51 gene was expressed, as well as on knockout mice, in which that gene was inactivated artificially. They found that the knockout mice did not gain weight after exposure to the diet, had better glucose, or blood sugar, tolerance, and had more effective insulin signaling. This allowed the researchers to understand that the FKBP51 protein – regulated by the gene with the same name – affects signaling pathways in skeletal muscles. Since the protein is sensitive to metabolic stress factors, such as high fat intake, it can ultimately lead to blood sugar buildup and insulin resistance. These are the main factors to blame in the development of type 2 diabetes and obesity. “FKBP51 influences a signaling cascade in muscle tissue, which with excessive calorie intake leads to the development of glucose intolerance, i.e., the key indicator of diabetes type 2.” Mathias Schmidt The cause may lead to the treatment Fortunately, this mechanism has also offered the scientists an insight into how they might be able to prevent FKBP51’s response to the stressors created by a high-fat diet. The answer, they say, lies in SAFit2, which is an FKBP51 antagonist compound, or a chemical able to block the action of the stress protein. Ongoing treatment with SAFit2, Schmidt and colleagues explain, could imitate the effect of the inactivated gene in knockout mice, leading to better “body weight regulation and glucose tolerance,” thus preventing the onset of diabetes. SAFit2 was developed by Felix Hausch, formerly of the Max Planck Institute of Psychiatry, who now works at the University of Darmstadt in Germany. The researchers plan on continuing to improve the compound and testing it in future clinical trials, in the hope that this may lead to new and more effective treatments for diabetes and other metabolic disorders. Read more……>click Here< Read more…